Diabetes Mellitus(ISSN:2072-0351)

Markers of inflammation, fibrosis, endothelial dysfunction, and podocytopathy in patients with long-term type 1 diabetes mellitus

A comprehensive assessment of biomarkers involved in the development of systemic inflammation in patients with long-term type 1 diabetes mellitus (T1D), accompanied by the development and progression of cardiac and renal pathology, may allow stratification of patients according to specific inflammatory activity and help in the search for new therapeutic prevention and treatment options. To eval

Medication Adherence in Patients with Diabetes Mellitus and Influencing Factors in Indonesia

Diabetes Mellitus significantly impacts the quality of human resources and substantially increases healthcare costs. Good adherence to diabetes treatment can control blood sugar levels and minimize hospitalization. To determine the medication adherence profile in patients with diabetes mellitus and the influencing factors. A cross-sectional study was used in Kalinyamatan Primary Health Center,

Novel cardioprotective and nephroprotective combination in patients with type 2 diabetes and chronic kidney disease: perspectives of use

Chronic kidney disease (CKD) is a common complication of diabetes mellitus. It increases significantly cardiovascular risk and decreases the quality of life. CKD requires treatment, and the treatment paradigm for type 2 diabetes has shifted from a glucose-centric approach towards disease-modifying therapy. Attention is being paid to cardioprotective and nephroprotective effects. In patients wit

Serum biomarkers associated with liver fibrosis in patients with type 2 diabetes

The diagnosis of liver fibrosis is an important task in the management of patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. The currently used diagnostic methods have a number of disadvantages such as invasiveness and high cost, or insufficient sensitivity and specificity. Therefore, the search for new non-invasive markers of liver fibrosis remains an actual challenge

Clinical prediction model for MODY type diabetes mellitus in children

MODY (maturity-onset diabetes of the young) is a rare monogenic form of diabetes mellitus, the gold standard of diagnosis is mutations detection in the genes responsible for the development of this form diabetes. Genetic test is expensive and takes a lot of time. The diagnostic criteria for MODY are well known. The development of clinical decision support system (CDSS) which allows physicians b

Diabetes Mellitus(ISSN:2072-0351)